Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo

被引:0
|
作者
Ching-I Huang
Ronald E. Crump
Paul E. Brown
Simon E. F. Spencer
Erick Mwamba Miaka
Chansy Shampa
Matt J. Keeling
Kat S. Rock
机构
[1] Zeeman Institute for System Biology and Infectious Disease Epidemiology Research,The Department of Statistics
[2] The University of Warwick,undefined
[3] Mathematics Institute,undefined
[4] The University of Warwick,undefined
[5] The School of Life Sciences,undefined
[6] The University of Warwick,undefined
[7] The University of Warwick,undefined
[8] Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA),undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Gambiense human African trypanosomiasis (sleeping sickness, gHAT) is a disease targeted for elimination of transmission by 2030. While annual new cases are at a historical minimum, the likelihood of achieving the target is unknown. We utilised modelling to study the impacts of four strategies using currently available interventions, including active and passive screening and vector control, on disease burden and transmission across 168 endemic health zones in the Democratic Republic of the Congo. Median projected years of elimination of transmission show only 98 health zones are on track despite significant reduction in disease burden under medical-only strategies (64 health zones if > 90% certainty required). Blanket coverage with vector control is impractical, but is predicted to reach the target in all heath zones. Utilising projected disease burden under the uniform medical-only strategy, we provide a priority list of health zones for consideration for supplementary vector control alongside medical interventions.
引用
收藏
相关论文
共 50 条
  • [1] Identifying regions for enhanced control of gambiense sleeping sickness in the Democratic Republic of Congo
    Huang, Ching-, I
    Crump, Ronald E.
    Brown, Paul E.
    Spencer, Simon E. F.
    Miaka, Erick Mwamba
    Shampa, Chansy
    Keeling, Matt J.
    Rock, Kat S.
    NATURE COMMUNICATIONS, 2022, 13 (01)
  • [2] Sleeping sickness in the Democratic Republic of the Congo
    Miaka, Erick M.
    Hasker, Epco
    Verle, Paul
    Torr, Steve J.
    Boelaert, Marleen
    LANCET NEUROLOGY, 2019, 18 (11): : 988 - 989
  • [3] The cost of sleeping sickness vector control in the Democratic Republic of the Congo
    Snijders, R.
    Fukinsia, A.
    Selby, R.
    Miaka, E.
    Tirados, I.
    Hope, A.
    Torr, S.
    Antillon, M.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 : 93 - 93
  • [4] The effectiveness of active population screening and treatment for sleeping sickness control in the Democratic Republic of Congo
    Robays, J
    Bilengue, MMC
    Van der Stuyft, P
    Boelaert, M
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2004, 9 (05) : 542 - 550
  • [5] High failure rates of melarsoprol for sleeping sickness, Democratic Republic of Congo
    Robays, Jo
    Nyamowala, Gaspard
    Sese, Claude
    Kande, Victor Betu Ku Mesu
    Lutumba, Pascal
    Van der Veken, Wim
    Boelaert, Marleen
    EMERGING INFECTIOUS DISEASES, 2008, 14 (06) : 966 - 967
  • [6] PRESENT STRATEGY AGAINST SLEEPING SICKNESS IN DEMOCRATIC-REPUBLIC-OF-CONGO
    FREZIL, JL
    COULM, J
    ANNALES DE LA SOCIETE BELGE DE MEDECINE TROPICALE, 1977, 57 (4-5): : 315 - 322
  • [7] The cost of sleeping sickness vector control in Yasa Bonga, a health district in the Democratic Republic of the Congo
    Snijders, Rian
    Shaw, Alexandra P. M.
    Selby, Richard
    Tirados, Inaki
    Bessell, Paul R.
    Fukinsia, Alain
    Miaka, Erick
    Tediosi, Fabrizio
    Hasker, Epco
    Antillon, Marina
    PLOS NEGLECTED TROPICAL DISEASES, 2024, 18 (11):
  • [8] Population genetics of Trypanosoma brucei gambiense in sleeping sickness patients with treatment failures in the focus of Mbuji-Mayi, Democratic Republic of the Congo
    Pyana, Patient Pati
    Sere, Modou
    Kabore, Jacques
    De Meeus, Thierry
    MacLeod, Annette
    Bucheton, Bruno
    Van Reet, Nick
    Buscher, Philippe
    Belem, Adrien Marie Gaston
    Jamonneau, Vincent
    INFECTION GENETICS AND EVOLUTION, 2015, 30 : 128 - 133
  • [9] Melarsoprol Sensitivity Profile of Trypanosoma brucei gambiense Isolates from Cured and Relapsed Sleeping Sickness Patients from the Democratic Republic of the Congo
    Pati, Patient Pyana
    Van Reet, Nick
    Ngoyi, Dieudonne Mumba
    Lukusa, Ipos Ngay
    Bin Shamamba, Stomy Karhemere
    Buscher, Philippe
    PLOS NEGLECTED TROPICAL DISEASES, 2014, 8 (10):
  • [10] Out-of-pocket expenses and their impact on sleeping sickness disease control activities in the Democratic Republic of the Congo
    Snijders, R.
    Mpanya, A.
    Hasker, E.
    Miaka, E.
    Antillon, M.
    Tediosi, F.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2021, 26 : 93 - 94